Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARAA
2226
DELISTED
Paramount Global Class A
PARAA
| $2.03M | ﹤0.01% |
50,203
-106,951
| -68% | -$4M |
|
2227
AtaiBeckley Inc
ATAI
$2.69B
| $2.03M | ﹤0.01% |
398,242
+139,242
| +54% | +$774K |
|
2228
Pulmonx
LUNG
$104M
| $2.02M | ﹤0.01% |
81,600
-71,700
| -47% | -$1.85M |
|
2229
iShares MSCI Germany ETF
EWG
$1.68B
| $2.02M | ﹤0.01% |
+71,200
| New | +$2.17M |
|
2230
Donnelley Financial Solutions
DFIN
$1.2B
| $2.02M | ﹤0.01% |
60,700
+28,100
| +86% | +$1M |
|
2231
West Pharmaceutical
WST
$24.6B
| $2.01M | ﹤0.01% |
4,900
+3,300
| +206% | +$1.29M |
|
2232
Cracker Barrel
CBRL
$1.29B
| $2.01M | ﹤0.01% |
+16,932
| New | +$2.1M |
|
2233
Franklin Electric
FELE
$4.68B
| $2M | ﹤0.01% |
24,100
+18,800
| +355% | +$1.61M |
|
2234
AstroNova
ALOT
$227M
| $2M | ﹤0.01% |
131,742
-25,800
| -16% | -$363K |
|
2235
abrdn Physical Silver Shares ETF
SIVR
$4.49B
| $2M | ﹤0.01% |
83,800
+73,100
| +683% | +$1.69M |
|
2236
SoundThinking
SSTI
$81.6M
| $2M | ﹤0.01% |
72,032
+9,300
| +15% | +$253K |
|
2237
Traeger
COOK
$164M
| $1.99M | ﹤0.01% |
5,358
+3,746
| +232% | +$1.79M |
|
2238
KVH Industries
KVHI
$145M
| $1.99M | ﹤0.01% |
218,800
-46,586
| -18% | -$417K |
|
2239
ACM Research
ACMR
$5.6B
| $1.98M | ﹤0.01% |
95,800
-157,100
| -62% | -$3.95M |
|
|
CLSD
2240
DELISTED
Clearside Biomedical
CLSD
| $1.98M | ﹤0.01% |
57,663
+29,049
| +102% | +$869K |
|
2241
Corsair Gaming
CRSR
$1.41B
| $1.98M | ﹤0.01% |
93,600
+54,426
| +139% | +$1.14M |
|
|
ADAP
2242
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.98M | ﹤0.01% |
959,703
+532,016
| +124% | +$1.44M |
|
|
TRT
2243
Trio-Tech International
TRT
$116M
| $1.97M | ﹤0.01% |
547,426
-53,848
| -9% | -$198K |
|
2244
Canadian Natural Resources
CNQ
$98.9B
| $1.97M | ﹤0.01% |
+64,936
| New | +$1.73M |
|
|
ESPR
2245
DELISTED
Esperion Therapeutics
ESPR
| $1.96M | ﹤0.01% |
+422,200
| New | +$1.81M |
|
|
ALYA
2246
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $1.96M | ﹤0.01% |
756,232
-15,600
| -2% | -$41.9K |
|
2247
Aspen Aerogels
ASPN
$485M
| $1.96M | ﹤0.01% |
56,700
+22,549
| +66% | +$732K |
|
2248
Origin Bancorp
OBK
$1.68B
| $1.95M | ﹤0.01% |
46,100
+7,380
| +19% | +$323K |
|
|
SWAV
2249
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.95M | ﹤0.01% |
9,400
-43,100
| -82% | -$7.11M |
|
|
GBL
2250
DELISTED
GAMCO Investors, Inc.
GBL
| $1.95M | ﹤0.01% |
88,000
+2,500
| +3% | +$55.4K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 821 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 821 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.